"TNFSF13" Related Products


Recombinant Human TNFSF13, Fc Chimera

Cat. No. : TNFSF13-2141H
Product Overview : Recombinant Human April extracellular domain (N-terminus fused with human IgG1Fc) produced in mammalian cells contains 373 amino acids with predicted MW 41.87 KD x 2 (dimmer) and 8 cysteines (Fc contains 6). It also has 2 N-link glycosylation sites with MW increase up to 10 KD.
Description : April competes with AGP3 binding to its receptor TACI and BCMA on T and B lymphoma cells , resulting in stimulation of proliferation of primary human and mouse B and T Cells. Well-documented antibodies are available to characterize human April protein.
Source : mammalian cells.
Purity : >90%.
Recommended Storage Temperature : -70 °C.
Gene Name : TNFSF13 tumor necrosis factor (ligand) superfamily, member 13 [ Homo sapiens ]
Synonyms : tumor necrosis factor (ligand) superfamily, member 13; APRIL; CD256; TALL2; TRDL-1; ligand; UNQ383/PRO715; TNFSF13; TALL-2; TNF-related death ligand 1; a proliferation inducing ligand; a proliferation-inducing ligand; tumor necrosis factor-related death ligand-1; TNF- and APOL-related leukocyte expressed ligand 2; tumor necrosis factor ligand superfamily member 13 epsilon; tumor necrosis factor (ligand) superfamily member 13 transcript variant delta;ZTNF2; A proliferation-inducing ligand; CD256 antigen
Gene ID : 8741
mRNA Refseq : NM_003808
Protein Refseq : NP_003799
MIM : 604472
UniProt ID : O75888
Chromosome Location : 17p13.1
Pathway : Cytokine-cytokine receptor interaction; Intestinal immune network for IgA production
Function : tumor necrosis factor receptor binding; cytokine activity; protein binding; receptor binding

Online Inquiry

Note: There will be extra charge for optional service!

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information

Optional requirements on this protein    +Expand

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.